Related Experiment Video
Updated: Dec 9, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Physiopathological and diagnostic aspects of cirrhotic cardiomyopathy
Talia M Leal-Alvarado1, Ignacio Escalante-Sandoval2, José L Gálvez-Romero3
1Echocardiographic Cardiology, Hospital Regional ISSSTE Puebla. Puebla, Mexico.
Insights
Cirrhotic cardiomyopathy involves heart problems in liver cirrhosis patients. Early detection using echocardiography, including longitudinal strain, is crucial for better patient outcomes.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Cirrhotic cardiomyopathy (CC) presents cardiac structural and functional changes in liver cirrhosis patients.
- It's linked to poor treatment response in portal hypertension and worse transplant outcomes.
- Despite being known since 1953, CC is underdiagnosed and poorly understood.
Purpose of the Study:
- To highlight the characteristics and diagnostic approaches for cirrhotic cardiomyopathy.
- To emphasize the clinical significance and underdiagnosis of this condition.
- To discuss the role of echocardiography and emerging techniques in CC detection.
Main Methods:
- Review of clinical characteristics of cirrhotic cardiomyopathy.
- Discussion of diagnostic utility of echocardiography, including E/A index and ejection fraction.
- Exploration of advanced techniques like longitudinal strain for early detection.
Main Results:
- CC involves diastolic and systolic dysfunction, electrical conduction abnormalities (QTc prolongation), and blunted chronotropic response.
- Echocardiography, particularly the E/A index, is a practical diagnostic tool.
- Pharmacological stress echocardiography aids in detecting latent forms of systolic dysfunction.
Conclusions:
- Cirrhotic cardiomyopathy is an underdiagnosed complication of liver cirrhosis with significant clinical implications.
- Echocardiography is key for diagnosis, with longitudinal strain showing promise for early detection.
- Improved recognition and diagnostic strategies are needed for better patient management and outcomes.
Abstract:
Cirrhotic cardiomyopathy is characterized by the presence of structural and functional cardiac alterations in patients suffering from hepatic cirrhosis, without previously known cardiac causes that may explain it. Clinically, it is characterized by the presence of variable grades of diastolic and systolic dysfunction (SD), alterations in the electric conductance (elongation of corrected QT interval) and inadequate chronotropic response. This pathology has been related to substandard response in the management of patients with portal hypertension and poor outcome after transplant. Even when the first description of this pathology dates back from 1953, it remains a poorly studied and frequently underdiagnosed entity. Echocardiography prevails as a practical diagnostic tool for this pathology since simple measurements as the E/A index can show diastolic dysfunction. SD discloses as a diminished ejection fraction of the left ventricle and the latent forms are detected by echocardiography studies with pharmacological stress. In recent years, new techniques such as the longitudinal strain have been studied and they seem promising for the detection of early alterations.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis II: Clinical features and Diagnostic Tests

